The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction

Journal of Urology

Volumn 168, Issue 2, 2002, Pages 610-614

  Dotan, Zohar A ^a   Mor, Yoram ^b   Leibovitch, Ilan ^b   Varon, David ^b   Golomb, Jacob ^b   Duvdevani, Mordechai ^b   Ramon, Jacob ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

Anticoagulants; Heparin; Molecular weight; Transurethral resection of prostate; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; DALTEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLADDER NECK STENOSIS; BLOOD TRANSFUSION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG WITHDRAWAL; HOSPITALIZATION; HUMAN; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOEMBOLISM; TRANSURETHRAL RESECTION; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0036077241     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)64689-7     Document Type: Article

References (28)

1. Immediate and postoperative complications of transurethral prostatectomy in the 1990s
2. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation
3. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The anticoagulation and risk factors in atrial fibrillation (ATRIA) study
4. Preventing stroke in patients with atrial fibrillation
5. Transurethral resection of the prostate and bladder tumour without withdrawal of warfarin therapy
6. Urologic surgery and the anticoagulated patient
7. Management of anticoagulation before and after elective surgery
8. Thrombotic risk factors associated with transurethral prostatectomy
9. Transurethral prostatic resection in patients with prosthetic cardiac valves
10. Transurethral resection of the prostate in the anticoagulated patient
11. Low molecular weight heparin(oid)s. Clinical investigations and practical recommendations
12. Bleeding effect of unfractionated heparin and low molecular weight heparins in an animal model
13. Low-molecular weight heparins
14. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: Update of previous meta-analysis
15. A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery
16. Use of enoxaparin for the chronically anticoagulated patient before and after procedures
17. Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: A double-blind, randomized comparison
18. Low molecular weight heparin after mechanical heart replacement
19. Outpatient treatment of pulmonary embolism with dalteparin
20. Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism
21. Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis
22. Can all patients with deep vein thrombosis receive low-molecular-weight heparin in an outpatient setting?
23. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin
24. Clinical outcome 1 year after transurethral vaporization and resection of the prostate
25. A randomized prospective study of laser ablation of the prostate versus transurethral resection of the prostate in men with benign prostatic hyperplasia
26. A double-blind randomized controlled trial and economic evaluation of transurethral resection versus contact laser vaporization for benign prostatic enlargement: A 3 year follow-up
27. A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The CLasP study
28. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: The CLasP study